Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The Role of Positron Emission Tomography/Magnetic Resonance Imaging in Gynecological Malignancies

Virarkar, Mayur MD; Viswanathan, Chitra MD; Iyer, Revathy MD; de Castro Faria, Silvana MD; Morani, Ajaykumar MD; Carter, Brett MD; Ganeshan, Dhakshinamoorthy; Elsherif, Sherif MD; Bhosale, Priya R. MD

Journal of Computer Assisted Tomography: November/December 2019 - Volume 43 - Issue 6 - p 825–834
doi: 10.1097/RCT.0000000000000918
Abdominal Imaging
Buy

Accurate oncological staging for early detection is of utmost importance in patient care and increasing the overall patient survival outcome. Hybrid imaging in the form of positron emission tomography (PET)/computed tomography has been successfully implemented in oncological imaging and, where available, has been used consistently in patients with gynecologic malignancies. The implementation of PET/magnetic resonance imaging (MRI) enables high-quality assessment of gynecological malignancies by combining the diagnostic advantages of metabolic information of PET along with the high-resolution anatomical and functional information from the MRI to provide precise information about staging, recurrence, and metastases. This article will review the various applications of PET/MRI in gynecological cancer.

From the Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Received for publication May 9, 2019; accepted May 10, 2019.

Correspondence to: Mayur Virarkar, MD, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (e-mail: mayurvirarkar@gmail.com).

The authors declare no conflict of interest.

Online date: August 28, 2019

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.